カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の非感染性前部ブドウ膜炎治療市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Non-infectious Anterior Uveitis Treatment Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19463）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19463
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：97
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の非感染性前部ブドウ膜炎治療市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

非感染性前部ブドウ膜炎治療市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の非感染性前部ブドウ膜炎治療の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

非感染性前部ブドウ膜炎治療市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・ステロイド薬、免疫抑制薬、その他

用途別セグメントは次のように区分されます。
・病院、眼科、在宅医療、その他

世界の非感染性前部ブドウ膜炎治療市場の主要な市場プレーヤーは以下のとおりです。
・Bausch & Lomb、Santen Pharmaceutical、AbbVie、OKYO、Novartis、Eyegate Pharmaceuticals、Regeneron Pharmaceuticals、Eyepoint pharmaceuticals、Alimera Sciences

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、非感染性前部ブドウ膜炎治療製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な非感染性前部ブドウ膜炎治療メーカーの企業概要、2019年～2022年までの非感染性前部ブドウ膜炎治療の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な非感染性前部ブドウ膜炎治療メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別非感染性前部ブドウ膜炎治療の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの非感染性前部ブドウ膜炎治療の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での非感染性前部ブドウ膜炎治療市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および非感染性前部ブドウ膜炎治療の産業チェーンを掲載しています。
・第13、14、15章では、非感染性前部ブドウ膜炎治療の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 非感染性前部ブドウ膜炎治療の概要
- 種類別分析（2017年vs2021年vs2028年）：ステロイド薬、免疫抑制薬、その他
- 用途別分析（2017年vs2021年vs2028年）：病院、眼科、在宅医療、その他
- 世界の非感染性前部ブドウ膜炎治療市場規模・予測
- 世界の非感染性前部ブドウ膜炎治療生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Bausch & Lomb、Santen Pharmaceutical、AbbVie、OKYO、Novartis、Eyegate Pharmaceuticals、Regeneron Pharmaceuticals、Eyepoint pharmaceuticals、Alimera Sciences
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：ステロイド薬、免疫抑制薬、その他
・用途別分析2017年-2028年：病院、眼科、在宅医療、その他
・非感染性前部ブドウ膜炎治療の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・非感染性前部ブドウ膜炎治療のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・非感染性前部ブドウ膜炎治療のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・非感染性前部ブドウ膜炎治療の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・非感染性前部ブドウ膜炎治療の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Non-infectious Anterior Uveitis Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Non-infectious Anterior Uveitis Treatment market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospitals accounting for % of the Non-infectious Anterior Uveitis Treatment global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Corticosteroid Drug segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Non-infectious Anterior Uveitis Treatment include Bausch & Lomb, Santen Pharmaceutical, AbbVie, OKYO, and Novartis, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Non-infectious Anterior Uveitis Treatment market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Corticosteroid Drug
Immunosuppressant Drug
Others
Market segment by Application can be divided into
Hospitals
Eye Clinics
Home Treatment
Others
The key market players for global Non-infectious Anterior Uveitis Treatment market are listed below:
Bausch & Lomb
Santen Pharmaceutical
AbbVie
OKYO
Novartis
Eyegate Pharmaceuticals
Regeneron Pharmaceuticals
Eyepoint pharmaceuticals
Alimera Sciences
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Non-infectious Anterior Uveitis Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Non-infectious Anterior Uveitis Treatment, with price, sales, revenue and global market share of Non-infectious Anterior Uveitis Treatment from 2019 to 2022.
Chapter 3, the Non-infectious Anterior Uveitis Treatment competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Non-infectious Anterior Uveitis Treatment breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Non-infectious Anterior Uveitis Treatment market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-infectious Anterior Uveitis Treatment.
Chapter 13, 14, and 15, to describe Non-infectious Anterior Uveitis Treatment sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Non-infectious Anterior Uveitis Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Non-infectious Anterior Uveitis Treatment Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Corticosteroid Drug
1.2.3 Immunosuppressant Drug
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Non-infectious Anterior Uveitis Treatment Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Eye Clinics
1.3.4 Home Treatment
1.3.5 Others
1.4 Global Non-infectious Anterior Uveitis Treatment Market Size & Forecast
1.4.1 Global Non-infectious Anterior Uveitis Treatment Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Non-infectious Anterior Uveitis Treatment Sales in Volume (2017-2028)
1.4.3 Global Non-infectious Anterior Uveitis Treatment Price (2017-2028)
1.5 Global Non-infectious Anterior Uveitis Treatment Production Capacity Analysis
1.5.1 Global Non-infectious Anterior Uveitis Treatment Total Production Capacity (2017-2028)
1.5.2 Global Non-infectious Anterior Uveitis Treatment Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Non-infectious Anterior Uveitis Treatment Market Drivers
1.6.2 Non-infectious Anterior Uveitis Treatment Market Restraints
1.6.3 Non-infectious Anterior Uveitis Treatment Trends Analysis
2 Manufacturers Profiles
2.1 Bausch & Lomb
2.1.1 Bausch & Lomb Details
2.1.2 Bausch & Lomb Major Business
2.1.3 Bausch & Lomb Non-infectious Anterior Uveitis Treatment Product and Services
2.1.4 Bausch & Lomb Non-infectious Anterior Uveitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Santen Pharmaceutical
2.2.1 Santen Pharmaceutical Details
2.2.2 Santen Pharmaceutical Major Business
2.2.3 Santen Pharmaceutical Non-infectious Anterior Uveitis Treatment Product and Services
2.2.4 Santen Pharmaceutical Non-infectious Anterior Uveitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 AbbVie
2.3.1 AbbVie Details
2.3.2 AbbVie Major Business
2.3.3 AbbVie Non-infectious Anterior Uveitis Treatment Product and Services
2.3.4 AbbVie Non-infectious Anterior Uveitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 OKYO
2.4.1 OKYO Details
2.4.2 OKYO Major Business
2.4.3 OKYO Non-infectious Anterior Uveitis Treatment Product and Services
2.4.4 OKYO Non-infectious Anterior Uveitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Novartis
2.5.1 Novartis Details
2.5.2 Novartis Major Business
2.5.3 Novartis Non-infectious Anterior Uveitis Treatment Product and Services
2.5.4 Novartis Non-infectious Anterior Uveitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Eyegate Pharmaceuticals
2.6.1 Eyegate Pharmaceuticals Details
2.6.2 Eyegate Pharmaceuticals Major Business
2.6.3 Eyegate Pharmaceuticals Non-infectious Anterior Uveitis Treatment Product and Services
2.6.4 Eyegate Pharmaceuticals Non-infectious Anterior Uveitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Regeneron Pharmaceuticals
2.7.1 Regeneron Pharmaceuticals Details
2.7.2 Regeneron Pharmaceuticals Major Business
2.7.3 Regeneron Pharmaceuticals Non-infectious Anterior Uveitis Treatment Product and Services
2.7.4 Regeneron Pharmaceuticals Non-infectious Anterior Uveitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Eyepoint pharmaceuticals
2.8.1 Eyepoint pharmaceuticals Details
2.8.2 Eyepoint pharmaceuticals Major Business
2.8.3 Eyepoint pharmaceuticals Non-infectious Anterior Uveitis Treatment Product and Services
2.8.4 Eyepoint pharmaceuticals Non-infectious Anterior Uveitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Alimera Sciences
2.9.1 Alimera Sciences Details
2.9.2 Alimera Sciences Major Business
2.9.3 Alimera Sciences Non-infectious Anterior Uveitis Treatment Product and Services
2.9.4 Alimera Sciences Non-infectious Anterior Uveitis Treatment Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Non-infectious Anterior Uveitis Treatment Breakdown Data by Manufacturer
3.1 Global Non-infectious Anterior Uveitis Treatment Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Non-infectious Anterior Uveitis Treatment Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Non-infectious Anterior Uveitis Treatment
3.4 Market Concentration Rate
3.4.1 Top 3 Non-infectious Anterior Uveitis Treatment Manufacturer Market Share in 2021
3.4.2 Top 6 Non-infectious Anterior Uveitis Treatment Manufacturer Market Share in 2021
3.5 Global Non-infectious Anterior Uveitis Treatment Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Non-infectious Anterior Uveitis Treatment Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Non-infectious Anterior Uveitis Treatment Market Size by Region
4.1.1 Global Non-infectious Anterior Uveitis Treatment Sales in Volume by Region (2017-2028)
4.1.2 Global Non-infectious Anterior Uveitis Treatment Revenue by Region (2017-2028)
4.2 North America Non-infectious Anterior Uveitis Treatment Revenue (2017-2028)
4.3 Europe Non-infectious Anterior Uveitis Treatment Revenue (2017-2028)
4.4 Asia-Pacific Non-infectious Anterior Uveitis Treatment Revenue (2017-2028)
4.5 South America Non-infectious Anterior Uveitis Treatment Revenue (2017-2028)
4.6 Middle East and Africa Non-infectious Anterior Uveitis Treatment Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Non-infectious Anterior Uveitis Treatment Sales in Volume by Type (2017-2028)
5.2 Global Non-infectious Anterior Uveitis Treatment Revenue by Type (2017-2028)
5.3 Global Non-infectious Anterior Uveitis Treatment Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Non-infectious Anterior Uveitis Treatment Sales in Volume by Application (2017-2028)
6.2 Global Non-infectious Anterior Uveitis Treatment Revenue by Application (2017-2028)
6.3 Global Non-infectious Anterior Uveitis Treatment Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Non-infectious Anterior Uveitis Treatment Sales by Type (2017-2028)
7.2 North America Non-infectious Anterior Uveitis Treatment Sales by Application (2017-2028)
7.3 North America Non-infectious Anterior Uveitis Treatment Market Size by Country
7.3.1 North America Non-infectious Anterior Uveitis Treatment Sales in Volume by Country (2017-2028)
7.3.2 North America Non-infectious Anterior Uveitis Treatment Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Non-infectious Anterior Uveitis Treatment Sales by Type (2017-2028)
8.2 Europe Non-infectious Anterior Uveitis Treatment Sales by Application (2017-2028)
8.3 Europe Non-infectious Anterior Uveitis Treatment Market Size by Country
8.3.1 Europe Non-infectious Anterior Uveitis Treatment Sales in Volume by Country (2017-2028)
8.3.2 Europe Non-infectious Anterior Uveitis Treatment Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Non-infectious Anterior Uveitis Treatment Sales by Type (2017-2028)
9.2 Asia-Pacific Non-infectious Anterior Uveitis Treatment Sales by Application (2017-2028)
9.3 Asia-Pacific Non-infectious Anterior Uveitis Treatment Market Size by Region
9.3.1 Asia-Pacific Non-infectious Anterior Uveitis Treatment Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Non-infectious Anterior Uveitis Treatment Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Non-infectious Anterior Uveitis Treatment Sales by Type (2017-2028)
10.2 South America Non-infectious Anterior Uveitis Treatment Sales by Application (2017-2028)
10.3 South America Non-infectious Anterior Uveitis Treatment Market Size by Country
10.3.1 South America Non-infectious Anterior Uveitis Treatment Sales in Volume by Country (2017-2028)
10.3.2 South America Non-infectious Anterior Uveitis Treatment Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Non-infectious Anterior Uveitis Treatment Sales by Type (2017-2028)
11.2 Middle East & Africa Non-infectious Anterior Uveitis Treatment Sales by Application (2017-2028)
11.3 Middle East & Africa Non-infectious Anterior Uveitis Treatment Market Size by Country
11.3.1 Middle East & Africa Non-infectious Anterior Uveitis Treatment Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Non-infectious Anterior Uveitis Treatment Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Non-infectious Anterior Uveitis Treatment and Key Manufacturers
12.2 Manufacturing Costs Percentage of Non-infectious Anterior Uveitis Treatment
12.3 Non-infectious Anterior Uveitis Treatment Production Process
12.4 Non-infectious Anterior Uveitis Treatment Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Non-infectious Anterior Uveitis Treatment Typical Distributors
13.3 Non-infectious Anterior Uveitis Treatment Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Non-infectious Anterior Uveitis Treatment Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Non-infectious Anterior Uveitis Treatment Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Bausch & Lomb Basic Information, Manufacturing Base and Competitors
Table 4. Bausch & Lomb Major Business
Table 5. Bausch & Lomb Non-infectious Anterior Uveitis Treatment Product and Services
Table 6. Bausch & Lomb Non-infectious Anterior Uveitis Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Santen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 8. Santen Pharmaceutical Major Business
Table 9. Santen Pharmaceutical Non-infectious Anterior Uveitis Treatment Product and Services
Table 10. Santen Pharmaceutical Non-infectious Anterior Uveitis Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. AbbVie Basic Information, Manufacturing Base and Competitors
Table 12. AbbVie Major Business
Table 13. AbbVie Non-infectious Anterior Uveitis Treatment Product and Services
Table 14. AbbVie Non-infectious Anterior Uveitis Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. OKYO Basic Information, Manufacturing Base and Competitors
Table 16. OKYO Major Business
Table 17. OKYO Non-infectious Anterior Uveitis Treatment Product and Services
Table 18. OKYO Non-infectious Anterior Uveitis Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Novartis Basic Information, Manufacturing Base and Competitors
Table 20. Novartis Major Business
Table 21. Novartis Non-infectious Anterior Uveitis Treatment Product and Services
Table 22. Novartis Non-infectious Anterior Uveitis Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Eyegate Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Eyegate Pharmaceuticals Major Business
Table 25. Eyegate Pharmaceuticals Non-infectious Anterior Uveitis Treatment Product and Services
Table 26. Eyegate Pharmaceuticals Non-infectious Anterior Uveitis Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Regeneron Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 28. Regeneron Pharmaceuticals Major Business
Table 29. Regeneron Pharmaceuticals Non-infectious Anterior Uveitis Treatment Product and Services
Table 30. Regeneron Pharmaceuticals Non-infectious Anterior Uveitis Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Eyepoint pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Eyepoint pharmaceuticals Major Business
Table 33. Eyepoint pharmaceuticals Non-infectious Anterior Uveitis Treatment Product and Services
Table 34. Eyepoint pharmaceuticals Non-infectious Anterior Uveitis Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Alimera Sciences Basic Information, Manufacturing Base and Competitors
Table 36. Alimera Sciences Major Business
Table 37. Alimera Sciences Non-infectious Anterior Uveitis Treatment Product and Services
Table 38. Alimera Sciences Non-infectious Anterior Uveitis Treatment Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Non-infectious Anterior Uveitis Treatment Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Non-infectious Anterior Uveitis Treatment Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Non-infectious Anterior Uveitis Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Non-infectious Anterior Uveitis Treatment Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Non-infectious Anterior Uveitis Treatment Production Site of Key Manufacturer
Table 44. Non-infectious Anterior Uveitis Treatment New Entrant and Capacity Expansion Plans
Table 45. Non-infectious Anterior Uveitis Treatment Mergers & Acquisitions in the Past Five Years
Table 46. Global Non-infectious Anterior Uveitis Treatment Sales by Region (2017-2022) & (K Units)
Table 47. Global Non-infectious Anterior Uveitis Treatment Sales by Region (2023-2028) & (K Units)
Table 48. Global Non-infectious Anterior Uveitis Treatment Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Non-infectious Anterior Uveitis Treatment Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Non-infectious Anterior Uveitis Treatment Sales by Type (2017-2022) & (K Units)
Table 51. Global Non-infectious Anterior Uveitis Treatment Sales by Type (2023-2028) & (K Units)
Table 52. Global Non-infectious Anterior Uveitis Treatment Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Non-infectious Anterior Uveitis Treatment Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Non-infectious Anterior Uveitis Treatment Price by Type (2017-2022) & (US$/Unit)
Table 55. Global Non-infectious Anterior Uveitis Treatment Price by Type (2023-2028) & (US$/Unit)
Table 56. Global Non-infectious Anterior Uveitis Treatment Sales by Application (2017-2022) & (K Units)
Table 57. Global Non-infectious Anterior Uveitis Treatment Sales by Application (2023-2028) & (K Units)
Table 58. Global Non-infectious Anterior Uveitis Treatment Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Non-infectious Anterior Uveitis Treatment Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Non-infectious Anterior Uveitis Treatment Price by Application (2017-2022) & (US$/Unit)
Table 61. Global Non-infectious Anterior Uveitis Treatment Price by Application (2023-2028) & (US$/Unit)
Table 62. North America Non-infectious Anterior Uveitis Treatment Sales by Country (2017-2022) & (K Units)
Table 63. North America Non-infectious Anterior Uveitis Treatment Sales by Country (2023-2028) & (K Units)
Table 64. North America Non-infectious Anterior Uveitis Treatment Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Non-infectious Anterior Uveitis Treatment Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Non-infectious Anterior Uveitis Treatment Sales by Type (2017-2022) & (K Units)
Table 67. North America Non-infectious Anterior Uveitis Treatment Sales by Type (2023-2028) & (K Units)
Table 68. North America Non-infectious Anterior Uveitis Treatment Sales by Application (2017-2022) & (K Units)
Table 69. North America Non-infectious Anterior Uveitis Treatment Sales by Application (2023-2028) & (K Units)
Table 70. Europe Non-infectious Anterior Uveitis Treatment Sales by Country (2017-2022) & (K Units)
Table 71. Europe Non-infectious Anterior Uveitis Treatment Sales by Country (2023-2028) & (K Units)
Table 72. Europe Non-infectious Anterior Uveitis Treatment Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Non-infectious Anterior Uveitis Treatment Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Non-infectious Anterior Uveitis Treatment Sales by Type (2017-2022) & (K Units)
Table 75. Europe Non-infectious Anterior Uveitis Treatment Sales by Type (2023-2028) & (K Units)
Table 76. Europe Non-infectious Anterior Uveitis Treatment Sales by Application (2017-2022) & (K Units)
Table 77. Europe Non-infectious Anterior Uveitis Treatment Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Non-infectious Anterior Uveitis Treatment Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Non-infectious Anterior Uveitis Treatment Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Non-infectious Anterior Uveitis Treatment Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Non-infectious Anterior Uveitis Treatment Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Non-infectious Anterior Uveitis Treatment Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Non-infectious Anterior Uveitis Treatment Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Non-infectious Anterior Uveitis Treatment Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Non-infectious Anterior Uveitis Treatment Sales by Application (2023-2028) & (K Units)
Table 86. South America Non-infectious Anterior Uveitis Treatment Sales by Country (2017-2022) & (K Units)
Table 87. South America Non-infectious Anterior Uveitis Treatment Sales by Country (2023-2028) & (K Units)
Table 88. South America Non-infectious Anterior Uveitis Treatment Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Non-infectious Anterior Uveitis Treatment Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Non-infectious Anterior Uveitis Treatment Sales by Type (2017-2022) & (K Units)
Table 91. South America Non-infectious Anterior Uveitis Treatment Sales by Type (2023-2028) & (K Units)
Table 92. South America Non-infectious Anterior Uveitis Treatment Sales by Application (2017-2022) & (K Units)
Table 93. South America Non-infectious Anterior Uveitis Treatment Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Non-infectious Anterior Uveitis Treatment Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Non-infectious Anterior Uveitis Treatment Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Non-infectious Anterior Uveitis Treatment Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Non-infectious Anterior Uveitis Treatment Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Non-infectious Anterior Uveitis Treatment Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Non-infectious Anterior Uveitis Treatment Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Non-infectious Anterior Uveitis Treatment Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Non-infectious Anterior Uveitis Treatment Sales by Application (2023-2028) & (K Units)
Table 102. Non-infectious Anterior Uveitis Treatment Raw Material
Table 103. Key Manufacturers of Non-infectious Anterior Uveitis Treatment Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Non-infectious Anterior Uveitis Treatment Typical Distributors
Table 107. Non-infectious Anterior Uveitis Treatment Typical Customers
List of Figures
Figure 1. Non-infectious Anterior Uveitis Treatment Picture
Figure 2. Global Non-infectious Anterior Uveitis Treatment Revenue Market Share by Type in 2021
Figure 3. Corticosteroid Drug
Figure 4. Immunosuppressant Drug
Figure 5. Others
Figure 6. Global Non-infectious Anterior Uveitis Treatment Revenue Market Share by Application in 2021
Figure 7. Hospitals
Figure 8. Eye Clinics
Figure 9. Home Treatment
Figure 10. Others
Figure 11. Global Non-infectious Anterior Uveitis Treatment Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Non-infectious Anterior Uveitis Treatment Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Non-infectious Anterior Uveitis Treatment Sales (2017-2028) & (K Units)
Figure 14. Global Non-infectious Anterior Uveitis Treatment Price (2017-2028) & (US$/Unit)
Figure 15. Global Non-infectious Anterior Uveitis Treatment Production Capacity (2017-2028) & (K Units)
Figure 16. Global Non-infectious Anterior Uveitis Treatment Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Non-infectious Anterior Uveitis Treatment Market Drivers
Figure 18. Non-infectious Anterior Uveitis Treatment Market Restraints
Figure 19. Non-infectious Anterior Uveitis Treatment Market Trends
Figure 20. Global Non-infectious Anterior Uveitis Treatment Sales Market Share by Manufacturer in 2021
Figure 21. Global Non-infectious Anterior Uveitis Treatment Revenue Market Share by Manufacturer in 2021
Figure 22. Non-infectious Anterior Uveitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Non-infectious Anterior Uveitis Treatment Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Non-infectious Anterior Uveitis Treatment Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Non-infectious Anterior Uveitis Treatment Sales Market Share by Region (2017-2028)
Figure 26. Global Non-infectious Anterior Uveitis Treatment Revenue Market Share by Region (2017-2028)
Figure 27. North America Non-infectious Anterior Uveitis Treatment Revenue (2017-2028) & (USD Million)
Figure 28. Europe Non-infectious Anterior Uveitis Treatment Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Non-infectious Anterior Uveitis Treatment Revenue (2017-2028) & (USD Million)
Figure 30. South America Non-infectious Anterior Uveitis Treatment Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Non-infectious Anterior Uveitis Treatment Revenue (2017-2028) & (USD Million)
Figure 32. Global Non-infectious Anterior Uveitis Treatment Sales Market Share by Type (2017-2028)
Figure 33. Global Non-infectious Anterior Uveitis Treatment Revenue Market Share by Type (2017-2028)
Figure 34. Global Non-infectious Anterior Uveitis Treatment Price by Type (2017-2028) & (US$/Unit)
Figure 35. Global Non-infectious Anterior Uveitis Treatment Sales Market Share by Application (2017-2028)
Figure 36. Global Non-infectious Anterior Uveitis Treatment Revenue Market Share by Application (2017-2028)
Figure 37. Global Non-infectious Anterior Uveitis Treatment Price by Application (2017-2028) & (US$/Unit)
Figure 38. North America Non-infectious Anterior Uveitis Treatment Sales Market Share by Type (2017-2028)
Figure 39. North America Non-infectious Anterior Uveitis Treatment Sales Market Share by Application (2017-2028)
Figure 40. North America Non-infectious Anterior Uveitis Treatment Sales Market Share by Country (2017-2028)
Figure 41. North America Non-infectious Anterior Uveitis Treatment Revenue Market Share by Country (2017-2028)
Figure 42. United States Non-infectious Anterior Uveitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Non-infectious Anterior Uveitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Non-infectious Anterior Uveitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Non-infectious Anterior Uveitis Treatment Sales Market Share by Type (2017-2028)
Figure 46. Europe Non-infectious Anterior Uveitis Treatment Sales Market Share by Application (2017-2028)
Figure 47. Europe Non-infectious Anterior Uveitis Treatment Sales Market Share by Country (2017-2028)
Figure 48. Europe Non-infectious Anterior Uveitis Treatment Revenue Market Share by Country (2017-2028)
Figure 49. Germany Non-infectious Anterior Uveitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Non-infectious Anterior Uveitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Non-infectious Anterior Uveitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Non-infectious Anterior Uveitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Non-infectious Anterior Uveitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Non-infectious Anterior Uveitis Treatment Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Non-infectious Anterior Uveitis Treatment Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Non-infectious Anterior Uveitis Treatment Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Non-infectious Anterior Uveitis Treatment Revenue Market Share by Region (2017-2028)
Figure 58. China Non-infectious Anterior Uveitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Non-infectious Anterior Uveitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Non-infectious Anterior Uveitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Non-infectious Anterior Uveitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Non-infectious Anterior Uveitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Non-infectious Anterior Uveitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Non-infectious Anterior Uveitis Treatment Sales Market Share by Type (2017-2028)
Figure 65. South America Non-infectious Anterior Uveitis Treatment Sales Market Share by Application (2017-2028)
Figure 66. South America Non-infectious Anterior Uveitis Treatment Sales Market Share by Country (2017-2028)
Figure 67. South America Non-infectious Anterior Uveitis Treatment Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Non-infectious Anterior Uveitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Non-infectious Anterior Uveitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Non-infectious Anterior Uveitis Treatment Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Non-infectious Anterior Uveitis Treatment Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Non-infectious Anterior Uveitis Treatment Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Non-infectious Anterior Uveitis Treatment Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Non-infectious Anterior Uveitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Non-infectious Anterior Uveitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Non-infectious Anterior Uveitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Non-infectious Anterior Uveitis Treatment Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Non-infectious Anterior Uveitis Treatment in 2021
Figure 79. Manufacturing Process Analysis of Non-infectious Anterior Uveitis Treatment
Figure 80. Non-infectious Anterior Uveitis Treatment Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の炎症性眼疾患治療薬市場2022年：市場規模予測（～2028年）
  • 世界の前眼部アナライザー市場2022年：市場規模予測（～2028年）
  • 脊髄前ゴーンの世界市場 2022年-2026年
  • 世界の頸椎前板システム市場2022年：市場規模予測（～2028年）
  • 前腰部バットレスプレートシステムの世界市場2023年：丸バットレスワッシャー、ナローバットレスワッシャー、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19463 )"世界の非感染性前部ブドウ膜炎治療市場2022年：市場規模予測（～2028年）" (英文：Global Non-infectious Anterior Uveitis Treatment Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。